Original Article
Clinical characteristics, survival and prognostic nomogram for patients with esophageal mucinous adenocarcinoma: a SEER population-based analysis
Journal of Gastrointestinal Oncology
2024;
15
(5)
:2028-2040
.
(31 October 2024)
Hepatoid adenocarcinoma of the stomach: discrimination from conventional gastric adenocarcinoma with a computed tomography-based radiomics nomogram
Journal of Gastrointestinal Oncology
2024;
15
(5)
:2041-2052
.
(31 October 2024)
Development of a streamlined NGS-based TCGA classification scheme for gastric cancer and its implications for personalized therapy
Journal of Gastrointestinal Oncology
2024;
15
(5)
:2053-2066
.
(31 October 2024)
Identifying a CD8T cell signature in the tumor microenvironment to forecast gastric cancer outcomes from sequencing data
Journal of Gastrointestinal Oncology
2024;
15
(5)
:2067-2078
.
(31 October 2024)
Metastasis patterns and prognosis in patients with gastric cancer: a Surveillance, Epidemiology, and End Results-based analysis
Journal of Gastrointestinal Oncology
2024;
15
(5)
:2079-2087
.
(31 October 2024)
Magnetic resonance imaging-based radiomics in predicting the expression of Ki-67, p53, and epidermal growth factor receptor in rectal cancer
Journal of Gastrointestinal Oncology
2024;
15
(5)
:2088-2099
.
(31 October 2024)
Machine learning-based analysis identifies a 13-gene prognostic signature to improve the clinical outcomes of colorectal cancer
Journal of Gastrointestinal Oncology
2024;
15
(5)
:2100-2116
.
(31 October 2024)
Changing of gamma-H2AX in peripheral blood mononuclear cells during concurrent chemoradiation in locally advanced rectal cancer patients: a potential response predictor
Journal of Gastrointestinal Oncology
2024;
15
(5)
:2117-2128
.
(31 October 2024)
Characterizing PANoptosis gene signature in prognosis and chemosensitivity of colorectal cancer
Journal of Gastrointestinal Oncology
2024;
15
(5)
:2129-2144
.
(31 October 2024)
Construction of diagnostic models with machine-learning algorithms for colorectal cancer based on clinical laboratory parameters
Journal of Gastrointestinal Oncology
2024;
15
(5)
:2145-2156
.
(31 October 2024)
Plasma levels of progranulin, a tumorigenic protein, are persistently elevated during the first month after minimally invasive colorectal cancer resection
Journal of Gastrointestinal Oncology
2024;
15
(5)
:2157-2165
.
(31 October 2024)
Regorafenib monotherapy as the later-line treatment for elderly patients with metastatic colorectal cancer: a multicenter real-world study
Journal of Gastrointestinal Oncology
2024;
15
(5)
:2166-2177
.
(31 October 2024)
Trans-arterial chemo-emobilization (TACE) combined with laparoscopic portal vein ligation and terminal branches portal vein embolization for hepatocellular carcinoma: a novel conversion strategy
Journal of Gastrointestinal Oncology
2024;
15
(5)
:2178-2186
.
(31 October 2024)
A predictive model based on radiomics, clinical features, and pathologic indicators for disease-free survival after liver transplantation for hepatocellular carcinoma: a 7-year retrospective study
Journal of Gastrointestinal Oncology
2024;
15
(5)
:2187-2200
.
(31 October 2024)
Nomogram-based prognostic stratification for patients with large hepatocellular carcinoma: a population study of SEER database and a Chinese cohort
Journal of Gastrointestinal Oncology
2024;
15
(5)
:2201-2215
.
(31 October 2024)
Real-world experience of lenvatinib-based therapy in patients with advanced hepatocellular carcinoma
Journal of Gastrointestinal Oncology
2024;
15
(5)
:2216-2229
.
(31 October 2024)
Identification of DLAT as a potential therapeutic target via a novel cuproptosis-related gene signature for the prediction of liver cancer prognosis
Journal of Gastrointestinal Oncology
2024;
15
(5)
:2230-2251
.
(31 October 2024)
Evaluating the mitochondrial structure and gene expression profile of regenerated liver tissues in mice after 85% partial hepatectomy
Journal of Gastrointestinal Oncology
2024;
15
(5)
:2252-2264
.
(31 October 2024)
Development and validation of a prognostic nomogram for elderly-onset pancreatic neuroendocrine carcinoma: a prospective cohort study from the SEER database
Journal of Gastrointestinal Oncology
2024;
15
(5)
:2265-2276
.
(31 October 2024)
Initial adjustments in the dosage and rest period of gemcitabine plus cisplatin therapy for patients with incurable biliary tract cancer based on baseline estimated glomerular filtration rate (eGFR) values may be crucial for treatment outcomes and the preservation of renal function
Journal of Gastrointestinal Oncology
2024;
15
(5)
:2277-2285
.
(31 October 2024)
Application of integrin subunit genes in pancreatic cancer and the construction of a prognosis model
Journal of Gastrointestinal Oncology
2024;
15
(5)
:2286-2304
.
(31 October 2024)
Review Article
Unexpected peritoneal metastases diagnosed at the time of primary colon cancer resection: controversies regarding options for management
Journal of Gastrointestinal Oncology
2024;
15
(5)
:2305-2315
.
(31 October 2024)
Case Report
Rare germline chromosome 1 duplication identified in young male with colon cancer: a case report investigating causality
Journal of Gastrointestinal Oncology
2024;
15
(5)
:2316-2322
.
(31 October 2024)
Case Report: iMDT Corner
Complete response and long-term survival after short-course camrelizumab plus apatinib, hepatic arterial infusion chemotherapy, and transarterial chemoembolization in large and advanced hepatocellular carcinoma: a case report
Journal of Gastrointestinal Oncology
2024;
15
(5)
:2323-2329
.
(31 October 2024)
Patient-controlled analgesia with hydromorphone treatment for advanced colon cancer with severe pain in an older adult patient: a case report and literature review
Journal of Gastrointestinal Oncology
2024;
15
(5)
:2330-2337
.
(31 October 2024)
Editorial Commentary
Peroxisome proliferator-activated receptor gamma (PPAR-γ) activation through gut microbiota modulation as a novel therapeutic approach against anastomotic leak after colorectal cancer surgery
Journal of Gastrointestinal Oncology
2024;
15
(5)
:2338-2342
.
(31 October 2024)
Liposomal eribulin (E7389-LF) plus nivolumab: a potential treatment option for patients with advanced gastric cancer?
Journal of Gastrointestinal Oncology
2024;
15
(5)
:2343-2348
.
(31 October 2024)
Negative hyperselection beyond RAS: is a key tool for choosing the optimal maintenance treatment in metastatic colorectal cancer?
Journal of Gastrointestinal Oncology
2024;
15
(5)
:2349-2352
.
(31 October 2024)
The role of negative hyperselection in metastatic colorectal cancer
Journal of Gastrointestinal Oncology
2024;
15
(5)
:2353-2357
.
(31 October 2024)
DNA-dependent protein kinase inhibitor as a sensitizer of radiotherapy in locally advanced rectal cancer
Journal of Gastrointestinal Oncology
2024;
15
(5)
:2358-2362
.
(31 October 2024)
Is the transverse colon the new right?—similarities in EGFR drug response and prognosis
Journal of Gastrointestinal Oncology
2024;
15
(5)
:2363-2366
.
(31 October 2024)
BCLC stage C hepatocellular carcinoma: modern therapeutic strategies in the age of immunotherapy
Journal of Gastrointestinal Oncology
2024;
15
(5)
:2367-2371
.
(31 October 2024)
Editorial
Poor prognosis of hepatocellular carcinoma patients—how, why, and what?
Journal of Gastrointestinal Oncology
2024;
15
(5)
:2372-2375
.
(31 October 2024)
